Two clinical trials with Acetium® capsule for prevention of migraine-type headache have been concluded
Biohit Oyj Stock Exchange Release August 9th 2019 at 15.30 pm local time (EET)In 2014, Biohit Oyj initiated two clinical trials for prevention of migraine-type headache attacks, testing the efficacy of Acetium® capsule. Because of a slow patient enrollment, the trial was subsequently extended to two additional clinical centers abroad. Despite this extension, the originally planned cohort size was not completely reached. In the whole series, Acetium® failed to show an efficacy statistically superior to placebo. Although the study results were not positive for the whole cohort, subgroup